OpenVSafe by OpenVAERS
Search V-safe

4CR-20725-56201

3 vaccinations 1 coded response 16 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
440 / OH
Registered
2022-01-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-24
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-03
    Registered in v-safe
  4. 2022-01-03
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-03
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2022-01-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Diarrhea
    Adult check-in
  7. 2022-01-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2022-01-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2022-01-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2022-01-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2022-01-10
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  13. 2022-01-17
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-31
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-04-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-07-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  20. 2023-01-03
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Facial pain, Nasal congestion, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  21. 2023-01-03
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2023-01-04
  23. 2023-01-10

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Pfizer-BioNTech No
22021-04-24Pfizer-BioNTech No
32022-01-03Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-01-03 Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDFacial pain · · ✓
SDNasal congestion · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…